RCT: High-flow nasal cannula vs. conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia.
High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial – Critical Care
The post RCT: High-flow nasal cannula vs. conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia. appeared first on Links Medicus.
RCT: Efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes.
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial – JAMA Network Open Author Interview: Efficacy and Safety of Varenicline in Patients With Type 2 Diabetes – JAMA Commentary on Twitter This randomized clinical trial (CoEHAR) found the use of varenicline in smoking cessation programs […]
The post RCT: Efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes. appeared first on Links Medicus.
How common is long COVID? Why studies give different answers.
How common is long COVID? Why studies give different answers – Nature
The post How common is long COVID? Why studies give different answers. appeared first on Links Medicus.
RCT: Low-dose methylprednisolone does not improve outcomes in critically ill patients with severe community-acquired pneumonia.
Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia – Intensive Care Medicine
The post RCT: Low-dose methylprednisolone does not improve outcomes in critically ill patients with severe community-acquired pneumonia. appeared first on Links Medicus.
[Preprint] Open-label RCT: Baricitinib noninferior to Tocilizumab in hospitalized patients with severe COVID-19.
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial – medRxiv Related: Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial – The Lancet Respiratory Medicine Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated […]
The post [Preprint] Open-label RCT: Baricitinib noninferior to Tocilizumab in hospitalized patients with severe COVID-19. appeared first on Links Medicus.
Clues to long Covid: Scientists strive to unravel what is driving disabling symptoms.
Clues To Long Covid – Science
The post Clues to long Covid: Scientists strive to unravel what is driving disabling symptoms. appeared first on Links Medicus.
Consensus Study: A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research.
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study – The Lancet Respiratory Medicine News Release: Key outcomes of Long COVID identified in international consensus study – King’s College London Invited Commentary: Post-COVID-19 condition in children: a COS is urgently needed – The […]
The post Consensus Study: A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research. appeared first on Links Medicus.
Case-control study: Risk of long COVID associated with delta vs. omicron variants of SARS-CoV-2.
Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 – The Lancet News Release: Long COVID risk less during Omicron compared to Delta, study finds – King’s College London Commentaries: Expert reaction to study looking at long COVID prevalence associated with delta versus omicron variants of SARS-CoV-2 – Science Media Centre Omicron […]
The post Case-control study: Risk of long COVID associated with delta vs. omicron variants of SARS-CoV-2. appeared first on Links Medicus.
WHO Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines.
Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines – World Health Organization See also: Interim statement on the composition of current COVID-19 vaccines – World Health Organization Commentary on Twitter (thread – click for more) Current #COVID19 vaccines provide high levels of protection against severe disease and death from […]
The post WHO Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines. appeared first on Links Medicus.
Brief Review: Helmet noninvasive support in hypoxemic respiratory failure.
Helmet noninvasive support in hypoxemic respiratory failure – Intensive Care Medicine (if the link is paywalled, try this one) Commentary on Twitter Helmet noninvasive support in hypoxemic respiratory failure:⚙️ set‐up⛑ physiology of helmet interface: from most relevant feature to major drawbacks? clinical implicationsFree to read #FOAMcc on @yourICM ? https://t.co/qNE4Id5oBg pic.twitter.com/b2auLLlW9z — Intensive Care […]
The post Brief Review: Helmet noninvasive support in hypoxemic respiratory failure. appeared first on Links Medicus.